Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Herencia, Carmen ^a   Martínez Moreno, Julio M ^a   Herrera, Concepción ^a   Corrales, Fernando ^b   Santiago Mora, Raquel ^a   Espejo, Isabel ^a   Barco, Monserrat ^a   Almadén, Yolanda ^a   de la Mata, Manuel ^a   Rodríguez Ariza, Antonio ^a   Muñoz Castañeda, Juan R ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADENINE PHOSPHORIBOSYLTRANSFERASE; ALPHA5 INTEGRIN; BETA CATENIN; BETA1 INTEGRIN; CATHEPSIN B; CATHEPSIN D; CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DIPEPTIDYL PEPTIDASE IV; ENDOGLIN; FRIZZLED PROTEIN; FRIZZLED PROTEIN 3; HERMES ANTIGEN; INORGANIC PYROPHOSPHATASE; LACTATE DEHYDROGENASE; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; MICROSOMAL AMINOPEPTIDASE; PEPTIDYLPROLYL ISOMERASE; PROTEIN P53; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; TRANSGELIN; TROPOMYOSIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; WNT PROTEIN; BIOLOGICAL MARKER; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CANCER STEM CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LIVER CELL; LIVER CELL CARCINOMA; MESENCHYMAL STEM CELL; METASTASIS POTENTIAL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPHEROID CELL; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; CELL NUCLEUS; CYTOLOGY; GENE EXPRESSION PROFILING; LIVER TUMOR; METABOLISM; METHODOLOGY; MULTICELLULAR SPHEROID; PHYSIOLOGY; PROTEIN TRANSPORT; WNT SIGNALING PATHWAY;

BETA CATENIN; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION PROFILING; HEPATOCYTES; HUMANS; IMMUNOPHENOTYPING; LIVER NEOPLASMS; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; NEOPLASTIC STEM CELLS; PROTEIN TRANSPORT; SPHEROIDS, CELLULAR; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84859612119     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034656     Document Type: Article

References (59)

1. Haegebarth A, Clevers H, (2009) Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 174: 715-721.
2. Armengol C, Cairo S, Fabre M, Buendia MA, (2011) Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model. Int J Biochem Cell Biol 43: 265-270.
3. Nusse R, (2005) Wnt signaling in disease and in development. Cell Res 15: 28-32.
4. Tang N, Song WX, Luo J, Luo X, Chen J, et al. (2009) BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med 13: 2448-2464.
5. Laudes M, (2011) Role of WNT pathway in the determination of human mesenchymal stem cells into preadipocytes. J Mol Endocrinol 46 (2): R65-72.
6. Ishii K, Yoshida Y, Akechi Y, Sakabe T, Nishio R, et al. (2008) Hepatic differentiation of human bone marrow-derived mesenchymal stem cells by tetracycline-regulated hepatocyte nuclear factor 3beta. Hepatology 48: 597-606.
7. Yoshida Y, Shimomura T, Sakabe T, Ishii K, Gonda K, et al. (2007) A role of Wnt/beta-catenin signals in hepatic fate specification of human umbilical cord blood-derived mesenchymal stem cells. Am J Physiol Gastrointest Liver Physiol 293: G1089-G1098.
8. Ke Z, Zhou F, Wang L, Chen S, Liu F, et al. (2008) Down-regulation of Wnt signaling could promote bone marrow-derived mesenchymal stem cells to differentiate into hepatocytes. Biochem Biophys Res Commun 367: 342-348.
9. Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, et al. (2000) Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 19: 498-504.
10. Zulehner G, Mikula M, Schneller D, van ZF, Huber H, et al. (2010) Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. Am J Pathol 176: 472-481.
11. Monga SP, Micsenyi A, Germinaro M, Apte U, Bell A, (2006) beta-Catenin regulation during matrigel-induced rat hepatocyte differentiation. Cell Tissue Res 323: 71-79.
12. Wu XZ, (2008) Origin of cancer stem cells: the role of self-renewal and differentiation. Ann Surg Oncol 15: 407-414.
13. Marquardt JU, Factor VM, Thorgeirsson SS, (2010) Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J Hepatol 53: 568-577.
14. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, et al. (2004) Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23: 5095-5098.
15. Hamidouche Z, Hay E, Vaudin P, Charbord P, Schule R, et al. (2008) FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J 22: 3813-3822.
16. Mishra L, Banker T, Murray J, Byers S, Thenappan A, et al. (2009) Liver stem cells and hepatocellular carcinoma. Hepatology 49: 318-329.
17. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, et al. (2004) In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40: 1275-1284.
18. Basma H, Soto-Gutierrez A, Yannam GR, Liu L, Ito R, et al. (2009) Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 136: 990-999.
19. Iwamuro M, Komaki T, Kubota Y, Seita M, Kawamoto H, et al. (2010) Hepatic differentiation of mouse iPS cells in vitro. Cell Transplant 19: 841-847.
20. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, et al. (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51: 297-305.
21. Llovet JM, Bruix J, (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48: 1312-1327.
22. Rubio D, Garcia-Castro J, Martin MC, de la FR, Cigudosa JC, et al. (2005) Spontaneous human adult stem cell transformation. Cancer Res 65: 3035-3039.
23. Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, et al. (2005) Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 65: 3126-3135.
24. Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, et al. (2008) Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 452: 650-653.
25. Yamada S, Ohira M, Horie H, Ando K, Takayasu H, et al. (2004) Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene 23: 5901-5911.
26. Zimmermann A, (2005) The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis. Eur J Cancer 41: 1503-1514.
27. Monga SP, (2009) Role of Wnt/beta-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol 43 (7): 1021-9.
28. Jeng YM, Wu MZ, Mao TL, Chang MH, Hsu HC, (2000) Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett 152: 45-51.
29. Ranganathan S, Tan X, Monga SP, (2005) beta-Catenin and met deregulation in childhood Hepatoblastomas. Pediatr Dev Pathol 8: 435-447.
30. Chafey P, Finzi L, Boisgard R, Cauzac M, Clary G, et al. (2009) Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway. Proteomics 9: 3889-3900.
31. Martin J, Dufour JF, (2008) Tumor suppressor and hepatocellular carcinoma. World J Gastroenterol 14: 1720-1733.
32. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, et al. (1994) p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 54: 231-235.
33. Uchida Y, Tanaka S, Aihara A, Adikrisna R, Yoshitake K, et al. (2010) Analogy between sphere forming ability and stemness of human hepatoma cells. Oncol Rep 24: 1147-1151.
34. Cao L, Zhou Y, Zhai B, Liao J, Xu W, et al. (2011) Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol 11: 71-.
35. Fu BH, Wu ZZ, Qin J, (2010) Effects of integrins on laminin chemotaxis by hepatocellular carcinoma cells. Mol Biol Rep 37: 1665-1670.
36. Bhagwat SV, Lahdenranta J, Giordano R, Arap W, Pasqualini R, et al. (2001) CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97: 652-659.
37. Petrovic N, Schacke W, Gahagan JR, O'Conor CA, Winnicka B, et al. (2007) CD13/APN regulates endothelial invasion and filopodia formation. Blood 110: 142-150.
38. Haraguchi N, Ishii H, Mimori K, Tanaka F, Ohkuma M, et al. (2010) CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest 120: 3326-3339.
39. Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, et al. (1999) New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer 81: 814-821.
40. Huang J, Zhang X, Tang Q, Zhang F, Li Y, et al. (2011) Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma. J Clin Pathol 64: 343-348.
41. Piao LS, Hur W, Kim TK, Hong SW, Kim SW, et al. (2012) CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett 315: 129-137.
42. Shen Y, Cao D, (2012) Hepatocellular carcinoma stem cells: origins and roles in hepatocarcinogenesis and disease progression. Front Biosci (Elite Ed) 4: 1157-1169.
43. Chen X, Fu S, Chen F, Chen H, Chen Z, (2008) Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies. Oncol Rep 20: 979-985.
44. Liu Z, Ma Y, Yang J, Qin H, (2011) Upregulated and downregulated proteins in hepatocellular carcinoma: a systematic review of proteomic profiling studies. OMICS 15: 61-71.
45. Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, et al. (2002) Proteome database of hepatocellular carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci 771: 303-328.
46. Beaujouin M, Liaudet-Coopman E, (2008) Cathepsin D overexpressed by cancer cells can enhance apoptosis-dependent chemo-sensitivity independently of its catalytic activity. Adv Exp Med Biol 617: 453-461.
47. Srisomsap C, Sawangareetrakul P, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, et al. (2010) Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J Biomed Biotechnol 2010: 437143-.
48. Shen H, Cheng G, Fan H, Zhang J, Zhang X, et al. (2006) Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential. Proteomics 6: 528-537.
49. Li L, Chen SH, Yu CH, Li YM, Wang SQ, (2008) Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray. J Proteome Res 7: 611-620.
50. Fantin VR, St-Pierre J, Leder P, (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9: 425-434.
51. Chen S, Zhang M, Ma H, Saiyin H, Shen S, et al. (2008) Oligo-microarray analysis reveals the role of cyclophilin A in drug resistance. Cancer Chemother Pharmacol 61: 459-469.
52. Lim SO, Park SJ, Kim W, Park SG, Kim HJ, et al. (2002) Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun 291: 1031-1037.
53. Bharadwaj S, Prasad GL, (2002) Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. Cancer Lett 183: 205-213.
54. Yokoyama Y, Kuramitsu Y, Takashima M, Iizuka N, Toda T, et al. (2004) Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 4: 2111-2116.
55. Yeo M, Kim DK, Park HJ, Oh TY, Kim JH, et al. (2006) Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. Proteomics 6: 1158-1165.
56. Hirasawa Y, Arai M, Imazeki F, Tada M, Mikata R, et al. (2006) Methylation status of genes upregulated by demethylating agent 5-aza-2′-deoxycytidine in hepatocellular carcinoma. Oncology 71: 77-85.
57. Fan HZ, Liu H, Zhang C, Gao DM, Xue Q, et al. (2009) Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model. J Cancer Res Clin Oncol 135: 591-602.
58. Kotobuki N, Hirose M, Takakura Y, Ohgushi H, (2004) Cultured autologous human cells for hard tissue regeneration: preparation and characterization of mesenchymal stem cells from bone marrow. Artif Organs 28: 33-39.
59. Weiswald LB, Guinebretiere JM, Richon S, Bellet D, Saubamea B, et al. (2010) In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy. BMC Cancer 10: 106-.